Rating History for Immix Biopharma, Inc. (IMMX) by BofA Securities
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 6/18/2026 | Tazeen Ahmad | New Coverage | Buy (N/A) |
27.00 (N/A) |
9.13 (10.25) |
12.27% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 6/18/2026 | Tazeen Ahmad | New Coverage | Buy (N/A) |
27.00 (N/A) |
9.13 (10.25) |
12.27% | Details |